Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC
Conditions
PDAC
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Herlev and Gentofte University Hospital, Copenhagen, Denmark
Charité Universitätsmedizin Berlin, Berlin, Germany
Technische Universitaet Dresden - Universitaetsklinikum Carl Gustav Carus, Dresden, Germany
Universitaetsklinikum Heidelberg, Heidelberg, Germany
Contact: Study coordinator (Christoph Springfeld) · christoph.springfeld@med.uni-heidelberg.de · +49 6221 56 5615Universitaetsklinikum Leipzig - Universitaeren Krebszentrum (UCCL), Leipzig, Germany
Contact: Study coordinator (Albrecht Hoffmeister) · albrecht.hoffmeister@medizin.uni-leipzig.de · +493419712240Ludwig-Maximilians-Universitaet Muenchen (LMU) Klinikum der Universitaet Muenchen - Campus Grosshadern - Medizinische Klinik und Poliklinik III, München, Germany
University Hospital and Faculty of Medicine Eberhard Karls University Tübingen, Tübingen, Germany
Contact: Study coordinator (Wolfgang Bethge) · wolfgang.bethge@med.uni-tuebingen.de · +49 (0)7071 29-87121Amsterdam UMC - VU Medical Center, Amsterdam, Netherlands
Contact: Study coordinator (Johanna Willemijn Wilmink) · j.w.wilmink@amsterdamumc.nl · +31(0)204444321Radboud University Medical Center, Nijmegen, Netherlands
Karolinska University Hospital, Stockholm, Sweden
Contact: Study coordinator (Maximiliam Kordes) · maximilian.kordes@regionstockholm.se · 08-123-83611